Physician profile
Mallory Lit
NPI 1851814420
$3,698.01
in general payments reported to CMS, 2019-2025
17 companies · $55.12 in 2025
The $55.12 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,540 · 2022: $723 · 2023: $483 · 2024: $897 · 2025: $55.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Consulting Fee: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.05 |
| Consulting Fee | $280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,126.60 | 2021-2024 | Lynparza |
| Glaxosmithkline, LLC. | $1,119.90 | 2021-2024 | Zejula, Jemperli |
| Abbvie INC. | $276.58 | 2021-2022 | |
| Genmab U.S., INC. | $271.13 | 2022-2024 | Tivdak |
| Merck Sharp & Dohme LLC | $248.70 | 2022-2025 | Keytruda |
| Daiichi Sankyo INC. | $180.87 | 2021-2025 | Enhertu |
| Gynesonics, INC. | $147.83 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Immunogen, INC. | $107.45 | 2023 | Elahere |
| Genzyme Corporation | $36.00 | 2024 | |
| Convatec INC. | $33.34 | 2022 | |
| Celgene Corporation | $31.75 | 2022 | |
| Eisai INC. | $30.77 | 2024 | |
| Pfizer INC. | $21.29 | 2024 | |
| Janssen Biotech, INC. | $19.68 | 2023 | Darzalex |
| Foundation Medicine, INC. | $19.62 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $14.84 | 2024 | |
| Clovis Oncology, INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Lit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.